The protozoan parasites-malaria and chagas' disease

Blood Safety and Surveillance

Volumn , Issue , 2016, Pages 355-398

  Wendel, Silvano ^a  

^a HOSPITAL SÍRIO LIBANÊS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 16844387070     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (174)

1. Woolsey G. Transfusion for pernicious anaemia: two cases. Ann Surg 1911; 53:132-135.
2. Turc JM. Malaria and blood transfusion. In: Westphal RG, Carlson KB, Turc JM, eds. Emerging Global Patterns in Transfusion-Transmitted Infections. Arlington, VA: AABB, 1990:31-43.
3. International Forum: Which are the appropriate modifications of existing regulations designed to prevent the transmission of malaria by blood transfusion, in view of the increasing frequency of travel to endemic areas? Vox Sang 1987; 52:138-148.
4. WHO. World malaria situation in 1990. Weekly Ep Rec 1992; 67:161-168.
5. WHO. World malaria situation in 1990. Weekly Ep Rec 1992; 67:169-176.
6. Gilles HM, Warrell DA. Bruce-Chwatt's Essential Malariology. 3rd ed. London: Edward Arnold, 1993.
7. Bruce-Chwatt LJ. Transfusion malaria revisited. Trop Dis Bull 1982; 79:827-840.
8. Bruce-Chwatt LJ. Transfusion malaria. Bull WHO 1974; 50:337-346.
9. Bruce-Chwatt LJ. Blood transfusion and tropical disease. Trop Dis Bull 1972; 69:825-862.
10. Chataing B. Prevention du paludisme transfusionel. Rev Franc Transf Immunohematol 1988; 31:81-88.
11. Tabor E. Infectious Complications of Blood Transfusion. New York: Academic Press, 1982.
12. Nahlen BL, Lobel HO, Cannon SE, Campbell CC. Reassessment of blood donor selection criteria for the United States travellers to malarious areas. Transfusion 1991; 31:798-804.
13. WHO. The biology of malaria parasites. Technical Report Series 743. Geneva: World Health Organization, 1987.
14. López-Antuñano FJ, Schmunis G, eds. Diagnosis of malaria. Scientific Publication No. 512. Washington, DC: Pan American Health Organization, 1990.
15. Fairley NH. Trans R Soc Trop Med Hyg 1947; 40:621-676.
16. Council of Europe. Guide to the preparation, use and quality assurance of blood components. Strasbourg, 1992: 17.
17. Wells L, Ala FA. Malaria and blood transfusion. Lancet 1985; i:1317-1318.
18. Andrade JCR, Wanderley DMV. Malária induzida no Estado de São Paulo, Brasil. Rev Soc Bras Med Trop 1991; 24:157-161.
19. Ferreira MV, Camargo LMA, Carvalho ME, Ninomia RT, Garcia LAV, Santos FR. Prevalence and levels of IgG and IgM antibodies against Plasmodium falciparum and P. vivax in blood donors from Rondonia, Brazilian Amazon. Mem Inst Oswaldo Cruz 1993; 88(2):263-269.
20. Kiesslich D, Torres KL, Fraiji NA. Métodos de triagem para Malária em Doadores de Sangue de área Endêmica. Bol Soc Bras hematol Hemot 1997; 19:21-27.
21. Salutari P, Sica S, Chiusolo P, Micciulli G, Plaisant P, Nacci A, Antinori A, Leone G. Plasmodium vivax malaria after autologous bone marrow transplantation: an unusual complication. Bone M Transpl 1996; 18:805-806.
22. Talabiska DG, Komar MJ, Wytock DH, Rubin RA. Post-transfusion acquired malaria complicating orthotopic liver transplantation. Am J Gastroenterol 1996; 91:376-379.
23. Tran VB, Tran VB, Lin KH. Malaria infection after allogeneic bone marrow transplantation in a child with talassemia. Bone M Transpl 1997; 19:1259-1260.
24. Ibhanesebor SE, Otobo ES, Ladipo OA. Prevalence of malaria parasitemia in transfused donor blood in Benin City, Nigeria. Ann Trop Ped 1996; 16:93-95.
25. Standards for Blood Banks and Transfusion Services-AABB, 15th ed. Bethesda, MD: 1993.
26. Sazama K. Prevention of transfusional-transmitted malaria: Is it time to revisit the standards (editorial). Transfusion 1991; 31:786-788.
27. Chiodini PL, Hartley S, Hewitt PE, Barbara JAJ, Lalloo K, Bligh J, Voller A. Evaluation of a malaria antibody ELISA and its value in reducing potential wastage of red cell donations from blood donors exposed to malaria, with a note on a case of transfusion-transmitted malaria. Vox Sang 1997; 73:143-148.
28. BPAC considers malaria deferral, ICL study, plasma source. Blood Bank Week 10(25):1n4.
29. Choudhury N, Jolly JG, Mahajan RC, Dubey ML, Kalra A, Ganguly NK. Selection of blood donors in malaria endemic countries. Lancet 1988; ii:972-973.
30. Smith OM, Traul DL, McOlash L, Sieber F. Evaluation of merocyanine 540-sensitized photoirradiation as a method of purging malarially infected red cells from blood. J Infect Dis 1991; 163:1312-1317.
31. Smith OM, Dolan AS, Dvorak JA. Merocyanine 540-sensitized photoinactivation of human erythocytes parasitized by Plasmodium falciparum. Blood 1992; 80:21-24.
32. Lustigman S, Ben-Hur E. Photosensitized inactivation of Plasmodium falciparum in human red cells by phthalocyanines. Transfusion 1996; 36:543-546.
33. Ben-Hur E, Horowitz B. Advances in photochemical approaches for blood sterilization. Photochem Photobiol 1995; 62:383-388.
34. Amato Neto V, Sant'Ana EJ, Pinto PLS, Moura AAB, Duarte MFS, Campos R. Estudo experimental sobre a possibilidade de prevençã da malária pós transfusional através do uso de violeta de genciana. Rev Saúde Publ S Paulo 1987; 21(6):497-500.
35. Draper CC, Sirr SS. Serological investigation in retrospective diagnosis of malaria. Br J Med 1980; 2:1575-1576.
36. Parra ME, Evans CB, Taylor DW. Identification of Plasmodium falciparum histidine-rich protein 2 in the plasma of humans with malaria. J Clin Microbiol 1991; 29:1629-1634.
37. Taylor DW, Voller A. The development of a simple antigen detection ELISA for Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87:29-31.
38. Namsiriponpun V, Wilde H, Pamsandang P, Tiersansern P. Field study of an antigen-detection ELISA specific for Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg 1993; 87:32-34.
39. Peyron F, martet G, Vigier JP. Dipstick antigen-capture assay for malaria detection. Lancet 343:1502-1503.
40. Avila SLM, Leandro MC, Carvalho NB, Oliveira MS, Arruk VG, Sanchez MCA, Boulos M, Ferreira AW. Evaluation of different methods for "plasmodia" detection in well defined population groups in an endemic area of Brazil. Rev Inst Med Trop São Paulo 1994; 36:157-162.
41. Hong VT, VanBe T, Tran PN, Thanh LT, Hien LV, O'Brien E, Morris GE. Screening donor blood for malaria by polymerase chain reaction. Trans R Soc Trop Med Hyg 1995; 89:44-47.
42. Chikwem JO, Mohammed I, Okara GC, Ukwandu NCD, Ola TO. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri teaching hospital, Maiduguri, Nigeria. East Afr Med J 1997; 74:213-216.
43. Chagas C. Nova espécie morbida do homem, produczida por um Trypanosoma (trypanosoma cruzi): Nota prévia. Brasil Méd 1909; 23:161.
44. Chagas C. Neue Trypanosomen. Arch Schiffs Tropenhyg 1909; 13:120-122.
45. Chagas C. über eine neue Trypanosomiasis des Menschen. Arch Schiffs Tropenhyg 1909; 13:351-353.
46. Chagas C. Nova tripanozomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.g., n.s.p., ajente etiolójico de nova entidade mórbida no homem. Mem Inst Oswaldo Cruz 1909; 1:159-218.
47. Chagas C. Nova entidade mórbida do homem. Resumo geral de estudos etiolójicos e clínicos. Mem Inst Oswaldo Cruz 1911; 3:219-275.
48. Chagas C. The discovery of Trypanosoma cruzi and of American trypanosomiasis. Mem Inst Oswaldo Cruz 1922; 15:1-11.
49. Chagas Filho C. Carlos Chagas-Ofícina Gráfica da Universidade do Brazil, 1959.
50. Mazza S, Montana A, Benitez C, Juzin E. Transmisión de "Schizotrypanum cruzi" al niño por leche de la madre con enfermedad de Chagas. Publ MEPRA 28:41-46.
51. Pellegrino J. Transmissão da doença de Chagas pela transfusão de sangue. Primeiras comprovações sorológicas em doadores e candidatos a doadores de sangue. Rev Bras Med 1949; 6:297-301.
52. Faria P. Sifilis, Maleita, Doença de Chagas e Transfusão. Folia Clin Biol 1951; 17:113-117.
53. Freitas, JLP, Amato V, Sonntag R, Biancalana A, Nussenszweig V, Barreto JG. Primeiras verfícacões de transmissão acidental da moléstia de Chagas ao homem por transfusão de sangue. Rev Paul Med 1952; 40:36-40.
54. Nussenzweig V, Sonntag R, Biancalana A, Freitas JLP, Amato Neto V, et al. Ação de corantes tri-fenil-metanicos sobre o Trypanosoma cruzi "in vitro." Emprego da Violeta de Genciana na profílaxia da transmissão da Moléstia de Chagas por transfusão de sangue. O Hospital 1953; 44:731-744.
55. Geiseler PJ, Ito JI, Tegtemeier BR, Kerndt PR, Krance R. Fulminant Chagas' disease in bone marrow transplantation. 27th Intersc. Conf. on Antimicro Agents and Chemoter. Washington: Am Soc for Microbiol 1987:418.
56. Grant I, Gold JWH, Wittnee M, et al. Transfusion associated acute Chagas' disease acquired in the United States. Ann Intern Med 1989; 111:849-851.
57. Nickerson P, Orr P, Schoeder MC, Sekla L, Johnson J. Transfusion associated Trypanosoma cruzi infection in a non endemic area. Ann Intern Med 1989; 111:851-853.
58. Cimo PL, Luper WE, Scouros MA. Transfusion-associated Chagas' disease in Texas: report of a case. Tex Med 1993; 89:48-50.
59. Lenes BA, Leiby DA, Tibbals MA, Olmedo M. A prospectively identified case of transfusion transmitted Trypanosoma cruzi: a defining window period. Transfusion 1998; 10 (suppl):390.
60. Leiby DA, Yund J, Read EJ, Lenes BS, Dodd RY. Risk factors for Trypanosoma cruzi infection in seropositive blood donors. Transfusion 1996; 36(suppl):228.
61. Galel S, Wolles S, Stumpf R. Evaluation of a selective donor testing strategy. Transfusion 1997; 37(suppl):296.
62. Leiby DA, Jensen NC, Fucci MC, Stumpf RJ. Prevalence of Trypanosoma cruzi antibodies in a blood donor population at low risk. Transfusion 1997; 37(suppl):297.
63. Schmunis GA. American trypanosomiasis as a Public Health Problem, in PAHO: Chagas' disease and the nervous system. Scientific Publication No. 547, Washington DC: 1994:3-29.
64. Hayes RJ, Schofield CJ. Estimación de las tasas de incidencia de infecciones y parasitosis crónícas a partir de la prevalencia: la enfermedad de Chagas en America Latina. Bol Of Sanit Panam 1990; 108:308-316.
65. Moncayo A. Chagas' disease. Tropical Disease Research. Progress 1991-92. Eleventh Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR). Geneva: World Health Organization, 1993:67-75.
66. World Bank. The World Bank Development Report 1993. Investing in Health. World development indicators. Washington: University Press, 1993.
67. Wendel S, Brener Z, Camargo M, Rassi A, eds. Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine. ISBT, Brasil '92, SBHH, 1992.
68. Miles MA. Further enzymic characters of Trypanosoma cruzi and their evaluation for strain identification. Trans Roy Sci Trop Med Hyg 1980; 74:221-237.
69. Miles MA. The epidemiology of South American trypanosomiasis-biochemical and immunological approaches and their relevance to control. Trans Roy Soc Trop Med Hyg 1983; 77:5-23.
70. Morel C, Chiari E, Plessman-Camargo E, Mattei D, Romanha AJ, Simpson L. Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles. Proc Natl Acad Sci USA 1980; 77:6810-6814.
71. Avila H, Gonçalves AM, Nehme NC, Morel CM, Simpson L. Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences. Mol Biochem Parasitol 1990; 42:175-188.
72. PAHO-OPS. III Reunión de la Comisión Intergubernamental para la Eliminación del Triatoma infestans y la interrupción de la tripanosomiais Americana Transfusional. OPS/HPC/HCT/94-37:1-21, Montevideo, Uruguay.
73. Nishioka AS, Ferreira MS, Rocha A, Burgarelli MKN, Silva AM, Duarte MIS, Schmitt FC. Reactivation of Chagas' disease successfully treated with benznidazole in a patient with acquired immunodeficiency syndrome. Mem Inst Oswaldo Cruz 1993; 88:493-496.
74. Chocair PR, Sabbaga E, Amato Net V, Shiroma M, Goes GM. Transplante de rim: nova modadlidade de transmissão da doença de Chagas. Rev Med Trop S Paulo 1981; 23:282-282.
75. Ferraz AS, Figueiredo JFC. Transmission of Chagas' disease through transplanted kidney: occurrence of the acute form of the disease in two recipients from the same donor. Rev Inst Med Trop S Paulo 1993; 35:461-463.
76. Dias JCP, Brener Z. Chagas' disease and blood transfusion. Mem Inst Oswaldo Cruz 1984; 79:139-147.
77. Schmuñis GA. Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and non endemic countries. Transfusion 1991; 31:547-557.
78. Wendel S, Gonzaga AL. Chagas disease and blood transfusion: a new world problem? Vox Sang 1993; 64:1-12.
79. Schmunis GA. Tripanosomíase Americana: seu impacto nas Américas e perspectivas de eliminacão. In: Dias JCP, Coura JR, eds. Clinica e terapêutica da Doença de Chagas. Rio de Janeiro: Edotora Fiocruz, 1997:411-427.
80. Wendel S. Doença de Chagas Transfusional. In: Dias JCP, Coura JR, eds. Clinica e terapêutica da Doença de Chagas. Rio de Janeiro: Edotora Fiocruz, 1997:411-427.
81. Wendel S, Neitzert E, Lopes VHG, Batemarchi MV. Evaluation of different screening tests for T. cruzi antibodies and correlation with immunoblotting technique. Rev Paul Med 1992; 110: Abstract TTD17.
82. Trujillo FC, Kasten FL, Gutiérrez MMS, Gutiérrez RH. Prevalencia de infección a Trypanosoma cruzi en donadores de sangre en el estado de Jalisco, Mexico. Rev Soc Bras Med Trop 1993; 26:89-92.
83. Ache A. Prevalencia de infección humana por Trypanosoma cruzi en Bancos de Sangre en Venezuela. Rev Inst Med Trop S Paulo 1993; 35:443-448.
84. Kerndt PR, Waskin HA, Kirhhoff LV, Steurer F, Waterman SH, Nelson JM, Gellert GA, Shulman IA. Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California. Transfusion 1991; 31:814-818.
85. Pan AA, Brashear J, Schur JD, Winkler MA, Hall H, Shih J, Decker R. Prevalence study and confirmation of seropositive antibodies to Trypanosoma cruzi (Chagas' disease) in Hispanic and Non-Hispanic blood donors in the United States. Rev Paul Med 1992; 110(5) (suppl.): Abstract TTD-18.
86. Read EJ, Leiby DA, Dodd RY. Seroprevalence of Trypanosoma cruzi (T. cruzi) in blood donors with and without risk infection. Blood 1994; 84 (suppl 1): Abstract 1853.
87. Winkler MA, Brashear RJ, Hall HJ, Schur JD, Pan AA. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. II-Evaluation of a supplemental enzyme immunoassay and radioimmuneprecipitation assay for confirmation of seroreactivity. Transfusion 1995; 35:219-225.
88. Leiby DA, Read EJ, Lenes BA, Yund AJ, Stumpf RJ, Kirchhoff LV, Dodd RY. Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. J Infect Dis 1997; 176:1047-1052.
89. Amato Neto V, Leonhardt H, Souza HBWT. Liofilização do plasma: Medida capaz de evitar a transmissão da Doença de Chagas em Bancos de Sangue. Rev Inst Med trop São Paulo 1966; 8:122-124.
90. Sullivan TS. Viability of Trypanosoma cruzi in citrated blood stored at room temperature. J Parasitol 1944; 30:200.
91. Weinman D, MacAlister J. Prolonged storage of human pathogenic protozoa with conservation of virulence. Am J Hyg 1947; 45:102-121.
92. Filardi LS, Brener Z. Cryopreservation of Trypanosoma cruzi bloodstream forms. J Protozool 1975; 22:398-401.
93. Schlemper BR Jr. Estudos experimentais de quimioprofílaxia de transmissão da doença de Chagas por transfusão sangüínea. Rev Patol Trop 1978; 7:55-111.
94. Cerisola JA, Rabinovich A, Alvarez M, Di Corleho CA, Pruneda J. Enfermedad de Chagas y la transfusion de sangre. Bol Of Sanit Panam 1972; 63:203-221.
95. Lorca M, Lorca J, Child R, Atias A, Conales M, et al. Prevalencia de la infección por Trypanosoma cruzi en pacientes politransfundidos. Rev Med Chile 1988; 116:112-116.
96. Villalba R, Fornés G, Alvarez MA, Román J, Rubio V, Fernandez M, Garcia JM, Viñals M, Torres A. Acute Chagas' disease in a recipient of a bone marrow transplant in Spain: case report. Clin Infect Dis 1992; 14:594-595.
97. World Health Organization. TDR News 1999; 59:10.
98. Wendel S. Transfusion-transmitted Chagas' disease. Curr Opin Hematol 1998; 5:406-411.
99. Kirchhoff LV, Neva FA. Chagas' disease in Latin American immigrants. JAMA 1985; 254:3058-3060.
100. Kirchhoff LV. Trypanosoma cruzi: a new threat to our blood transfusion supply (editorial). Ann Intern Med 1989; 111:773-775.
101. Kirchhoff LV. American trypanosomiasis (Chagas disease)-a tropical disease now in the United States. N Engl J Med 1993; 329:639-644.
102. Milei J, Mautner B, Storino R, Sanchez Já, Ferrans VS. Does Chagas' disease exist as an undiagnosed form of cardiomyopathy in the United States? (editorial). Am Heart J 1992; 123:1732-1735.
103. Wendel S. Chagas disease: an old entity in new places (editorial). Int J Art Organs 1993; 16:117-119.
104. Schmunis GA, Zicker F, Pinheiro F, Brandling-Bennett D. Risk for transfusiontransmitted infectious diseases in Central and South America. Emerg Inf Dis 1998; 4:5-11.
105. Coura JR, Nogueira ES, Silva JR. Indices de transmissão da doença de Chagas por transfusão de sangue de doadores na fase crônica da doença. O Hospital 1966; 69:115-122.
106. Rohwedder RW. Infección chagásica en doadores de sangre y las probabilidades de transmitirla por medio de la transfusion. Bol Chile Parasitol 1969; 24:88-93.
107. Zuna H, Recacoechea M, Bermudez H, Romero A, Castedo J. Transmissión de la enfermedad de Chagas por via transfusional en Santa Cruz de la Sierra, Bolivia. Bol Inf CENENTROP 1979; 5:49-56.
108. Vamvakas EC, Taswell HF. Long-term survival after blood transfusion. Transfusion 1994; 34:471-477.
109. Andrade ALLS, Martelli CMT, Loquetti AO, Oliveira OS, Silva AS, Zicker F. Triagem sorológica para o Trypanosmoa cruzi entre doadores de sangue do Brasil central. Bol Of Sanit Panam 1992; 113:19-27.
110. World Health Organization. Parasite antigens. Bull WHO 1975; 52:237-249.
111. World Health Organization. (WHO) report-Newsletter 1982; 18:7.
112. Cura E, Wendel S, eds. Manual de Procedimientos de Control de Calidad para los Laboratorios de Serologia de los Bancos de Sangre. PAHO/HPC/HPT/94.21, Washington DC, 1994.
113. Brazilian Ministery of Health, Portaria No. 1376, 1993.
114. Takei K. Estudo da eficiência relativa dos diferentes testes serológicos utilizados no diagnóstico da doença de Chagas. Resultados observados na análise de 10.181 soros; doctoral thesis. São Paulo Departamento de Microbiologia e Immunologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, 1982.
115. Lackritz, EM, Satten GA, Aberle-Grasse J et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med 2005; 333:1721-1725.
116. Wendel S, Siqueira RV, Lopes VHG, Batemarchi MV, Neitzert E, Antunes MF, Mejias S. Assessing the performance of Trypanosoma cruzi antibody detection currently in use in Brazilian blood centres: a few answers from a large prevalence study. Rev Paul Med 1992; 110(5):16.
117. Souza HM. Chagas Infection Transmission Control: Situation of Transfusional Transmission in Brazil and Other Countries of Latin America. Simósio Internacional Sobre Avanços do Conhecimento da Doença de Chagas 90 Anos após sua Descoberta. Rio de Janeiro, April 1999.
118. Gontijo ECD. Doença de Chagas Transfusional na Região Metropolitana de Belo Horizonte: aspectos clínico-epidemiológicos e a questão institucional. Thesis. Belo Horizonte, Universidade Federal de Minas Gerais, 1989.
119. Wendel S. Blood banking preventive approaches for Chagas disease. Mem Inst Oswaldo Cruz 1993; 88(suppl):59-60.
120. Zicker F, Martelli CMT, Andrade ALLS, Silva SA. Trends of T. cruzi infection based on data from blood bank screening. Rev Inst Med Trop S Paulo 1990; 39:132-137.
121. Wendel S, Biagini S. Absence of serological surrogate markers for Trypanosoma cruzi infected blood donors. Vox Sang 1995; 69:44-49.
122. Appleman MD, Shulman IA, Saxena S, Kirchhoff LV. Use of a questionnaire to identify potential blood doors at risk for infection with Trypanosoma cruzi. Transfusion 1993; 33:61-64.
123. World Health Organization/Panamerican Health Organization. Iniciativa del Cono Sur. VI Reunión Intergubernamental para la eliminación de Triatoma infestans y la interrupcón del la tripanosomiasis americana por transfusión. Documento OPS/HPC/HCT 98/102, 1997.
124. Freitas JLP, Biancalana A, Amato Neto, Nussenzweig V, Barreto JG. Moléstia de Chagas em Bancos de Sangue na capital de S Paulo. O Hospital 1952; 41:99-106.
125. Cover B, Gutteridge WE. A primary screen for drugs to prevent transmission of Chagas' disease during blood transfusion. Trans Roy Soc Trop Med Hyg 1982; 76:633-635.
126. Docampo R, Moreno SNJ, Muniz RP, Cruz FS, Mason RP. Light-enhanced free radical formation and trypanocidal action of gentian violet (crystal violet). Science 1983; 220:1292-1295.
127. Docampo R, Moreno SNJ. Free radicals metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Ver Inf Dis 1984; 6:223-238.
128. Docampo R, Moreno SNJ, Cruz F. Enhancement of the cytotoxicity of crystal violet against Trypanosoma cruzi in the blood by ascorbate. Mol Biochem parasitol 1988; 27:241-248.
129. Souza HM. The present state of chemoprophylaxis in transfusional Chagas' disease (editorial). Rev Soc Bras Med Trop 1989; 22:1-3.
130. Ramirez LE, Lages-Silva E, Painetti GM, Rabello RMC, Bordin JO, Souza HM. Prevention of transfusion-associated Chagas' disease by sterilization of Trypanosoma cruzi-infected blood with gentian violet, ascorbic acid, and light. Transfusion 1995; 35:226-230.
131. Amato Neto V, Mellone O. Estudo sobre a efícácia da Violeta de Genciana na profílaxia da transmissão da doença de Chagas em bancos de sangue: investigação em voluntário, receptor de sangue de caso agudo, ao qual foi adicionado o corante. O Hospital 1959; 55:343-346.
132. Schlemper BR Jr. Estudos experimentais de Quimio-profílaxia de transmissão da doença de Chagas por transfusão sangüínea. Rev Pat Trop 1978; 7:55-111.
133. Amato Neto V. Contribuição ao conhecimento da forma aguda da Doença de Chagas-Tese: Faculdade de Medicina da Universidade de São Paulo, 1958.
134. Rezende JM, Zupelli W, Bafutto M. O problema da transmissão da doença de Chagas por transfusão de sangue. Emprego da Violeta de Genciana como medida profílática. Ver Goiana Med 1965; 11:35-47.
135. Docampo R, Moreno SNJ. The metabolism and mode of action of gentian violet. Drug Met Rev 1990; 22:161-178.
136. Gottlieb P, Shen LG, Chimezie E, Bahng S, Keeney ME, Horowitz B, Bem-Hur E. Inactivation of Trypanosoma cruzi trypomastigote forms in blood component by photodynamic treatment with phthalocyanines. Photochem Photobiol 1995; 62:869-874.
137. Wendel S, Takaoka DT, Jancsó MM, Mariano M, Fragata Filho AA, Pereira-Chioccola Lourenco AM. A possible role of leukocyte filters to prevent transfusiontransmitted Trypanosoma cruzi. Vox Sang 1994; 67(suppl 2):22.
138. Souza HM, Bordin JO, Bordossy L, MacPhereson DW, Blajchman MA. Prevention of transfusion-associated Chagas' disease: efficacy of white cell-reduction filters in removing Trypanosoma cruzi from infected blood. Transfusion 1995; 35:723-726.
139. Wendel S, Takaoka DT, Jancsó MM, Mariano M, Leite KM, Chioccola VLP, Lorenço AM, Fragata Filho AA. Is there a role for leukocyte depletion filters to remove Trypanosoma cruzi infection from donor blood? Bol Soc Bras Hematol Hemot 1995; 17:25-31.
140. Moser DR, Kirchhoff LV, Donelson JE. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol 1989; 27:1477-1482.
141. Russomando G, Figueredo A, Almirón M, Sakamoto M, Morita K. Polymerase chain reaction-based detection of Trypanosoma cruzi DNA in serum. J Clin Microbiol 1992; 30:2864-2868.
142. Urbina J, Payares G, et al. Cure of short and long-term experimental Chagas' disease using D0870. Science 1996; 273:969-971.
143. Centurion-Lara A, Barrett L, van Voohis WC. Quantitation of parasitemia by competitive polymerase chain reaction amplification of parasite kDNA minicircles during chronic infection with Trypanosoma cruzi. J Infect Dis 1994; 170:1334-1338.
144. Lal RB, Ottesen EA. Phosphocoline epitopes on helminth and protozoal parasites and their presence in the circulation of infected human patients. Trans Roy Soc Trop Med Hug 1989; 83:652-655.
145. Ferreira AW. Serological diagnosis-tests for Chagas disease serodiagnosis: a review. In: Wendel S, Brener Z, Camaro ME, Rassi A, eds. Chagas Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine. São Paulo: ISBT, 1992: 179-193.
146. Sasaki AT, Hoshino-Shimizu S, Nakamura PM, Vaz AJ, Camargo ED, Silva MD. Sorodiagnóstico da doença de Chagas: novo reagente para o teste de Hemaglutinação indireta (THAIIAL). Rev Soc Bras Med Trop 1996; 29:137-144.
147. Luquetti AO. Use of Trypanosoma cruzi defined proteins for diagnosis-multicentre trial, serological and technical aspects. Mem Inst Oswaldo Cruz 1990; 85:497-505.
148. Zicker F, Smith PG, Luquetti AO, Oliveira OS. Mass screening for Trypanosoma cruzi infections using the immunofluorescence, ELISA and hemagglutination tests on serum samples and on blood eluates from filter paper. Bull WHO 1990; 68:465-471.
149. Andrade ALSS, Martelli CMT, Luquetti AO, Oliveira OS, Silva SA, Zicker F. Serologic screening for Trypanosoma cruzi among blood donors in central Brazil. Bull Pan Am Health Organ 1992; 26:157-164.
150. Fife EH Jr, Mushel LH. Fluorescent antibody technique for serodiagnosis of Trypanosoma cruzi infection. Proc Soc Exp Biol NY 1959; 101:540-543.
151. Camargo ME, Souza SL. The use of filter paper blood smears in a practical fluorescent test for American trypanosomiasis serodiagnosis. Rev Inst Med Trop S Paulo 1966; 8:255-258.
152. Velasquez L, Reyes L, Thors C, Miettinen A, Chinchella M, Linder E. Autoantibodies give false positive reactions in the serodiagnosis of Trypanosoma cruzi. Trans Roy Soc Trop Med Hyg 1993; 87:35.
153. Voller A, Draper C, Bidwell DE, Bartlett A. A micro-plate enzyme-linked immunosorbent assay (ELISA) for Chagas disease. Lancet 1975; 1:426-429.
154. Wendel S, Lopes VHG, Batemarchi MV, Takaoka DT, Neitzert E. High levels of false positive reaction for Trypanosoma cruzi antibodies tests used for blood donors screening. Transfusion 1993; 33(suppl):41S.
155. Carvalho MR, Krieger MA, Almeida E, Oelemann W, Shikanai-Yasuda MA, Ferreira AW, Pereira JB, Sáez-Alquézar A, Dorlhiac-Llacer PE, Chamone DF, Goldenberg S. Chagas' disease diagnosis: evaluation of several tests in blood bank screening. Transfusion 1993; 33;830-834.
156. Ferreira AW, Belem ZR, Moura MEG, Camargo ME. Aspectos da padronização de testes sorológicos para a Doença de Chagas: Um teste imunoenzimático para a triagem de doadores de sangue. Rev Inst Med Trop S Paulo 1991; 33:123-128.
157. Brashear RJ, Winkler MA, Schur JD, Lee H, Burczak JD, Hall HJ, Pan AA. Detection of antibodies to Trypanosoma cruzi among blood donors in the southwestern and western United States. I. Evaluation of the sensitivity and specificity of an enzyme immunoassay for detecting antibodies to T. cruzi. Transfusion 1995; 35:213-218.
158. Oelemann WMR, Teixeira MGM, Costa GCV et al. Evaluation of three commercial enzyme-linked imunosorbent assays for diagnosis of Chagas' disease. J Clin Microbiol 1998; 36:2423-2427.
159. Houghton RL, Benson D, Skeiky Y, Sleath P, Lodes M, Badaró R, Krettli A, Reed SG. Multi-epitope peptide elisa for detection of serum antibodies to Trypanosoma cruzi in patients with treated and untreated Chagas' disease. Transfusion 1996; 36(suppl):137.
160. Hoffman A, Jaczko B, Jones J, Tursi N, Lee SR. Evaluation of a prototype screening ELISA and supplemental analysis for the serological identification of Chagas disease. Transfusion 1997; 37(suppl):181.
161. Umezawa ES, Bastos SF, Camargo ME, Yamauchi LM, Santos MR, Gonzales A, Zingales B, Levin MJ, Souza O, Rangel-Adão R, Franco da Silveira J. Evaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America. J Clin Microbiol 1999; 37:1554-1560.
162. Lanar DE, Manning JE. Major surface proteins and antigens on the different in vivo and in vitro forms of Trypanosoma cruzi. Mol Biochem Paras 1984; 11:119-131.
163. Rosfjord EC, Mikhael KS, Rowland EC, Powell MR. Analysis of antibody crossreactivity in experimental american trypanosomiasis. J Parasitol 1990; 76:698-702.
164. Reiche EMV, Cavazzane M Jr., Okamura H, Tagata EC, Jankevicius SI, Jankevicius JV. Evaluation of the Western blot in the confirmatory serologic diagnosis of Chagas' disease. Am J Trop Med Hyg 1998; 59:750-756.
165. Teixeira MGM, Borges-Pereira J, Neitzert E, Souza MLNX, Peralta JM. Development and evaluation of an enzyme linked immunotransfer blot technique for serodiagnosis of Chagas' disease. Trop Med Parasitolo 1994; 45:308-312.
166. Pastini AC, Iglesias SR, Carricate VC, Guerin ME, Sanchez DO, Frasch AC. Immunoassay with recombinant Trapanosoma cruzi antigens potentially useful for screening donated blood and diagnosing Chagas disease. Clin Chem 1994; 40:1893-1897.
167. Sabino EC, Salles N, Stoops E, Santos ML, Saez-Alquezar A. Evaluation of Chagas Innolia assay as a confirmatory test for Chagas disease. Mem Inst Oswaldo Cruz 1997; 92(suppl 1):266.
168. Costa GCV, Teixeira MGM, Borges-Pereira J, Castro JAF, Coura JR, Vanderborght BOM, Stroops E, Zrein M, Peralta JM, Oelemann WMR. A recombinant antigen and peptide line immunoassay (LIA) as an alternative diagnostic test for Chagas' disease. Mem Inst Oswaldo Cruz 1997; 92(suppl 2):267.
169. Oelemann WMR, Vanderborght BOM, Veríssimo da Costa GC, Teixeira MGM, Borges-Pereira J, Castro JAF, Coura JR, Stoops E, Hulstaert F, Zrein M, Peralta JM. A recombinant peptide antigen line immunoassay optimized for the confirmation of Chagas' disease. Transfusion 1999; 39:711-717.
170. Kirchhoff LV, Gam AA, Gusmão RA, Goldsmith RS, Rezende JM, Rassi A. Increased specificity of serodiagnosis of Chagas' disease by detection of antibody to the 72-and 90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 1987; 155:561-564.
171. Leiby DA, Wendel S, Takaoka DT, Fachini R, Oliveira LC, Tibbals MA. Confirmatory testing for Trypanosoma cruzi antibodies: validation of radioimmuneprecipitation (RIPA) testing. Transfusion 1997; 37(suppl 95):5301.
172. Rassi A, Luquetti AO. Therapy of Chagas disease. In: Wendel S, Breuer Z, Camargo ME, Rassi A, eds. Chagas Disease (American Trypanosomiasis): Its Impact on Transfusion and Clinical Medicine. São Paulo: ISBT, 1992:237-247.
173. Andrade ALLS, Zicker F, Oliveira RM, Silva AS, Luquetti AO, Travassos LR, Almeida IC, Andrad SS, Andrade JG, Martelli CMT. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 1996; 348:1407-1412.
174. Dias JCP, Schofield CJ. Controle da transmissão transfusional da doença de Chagas na Iniciativa do Cone Sul. Rev Soc Bras Med Trop 1998; 31:373-383.